Cardioprotective Role of BGP-15 in Ageing Zucker Diabetic Fatty Rat (ZDF) Model: Extended Mitochondrial Longevity
Authors:
- Mate KozmaMKMate Kozma
- Mariann BombiczMBMariann Bombicz
- Balazs VargaBVBalazs Varga
- Daniel PrikszDPDaniel Priksz
- Rudolf GesztelyiRudolf Gesztelyi
- Vera TarjanyiVTVera Tarjanyi
- Rita KissRita Kiss
- Reka SzekeresRSReka Szekeres
- Barbara TakacsBTBarbara Takacs
- Akos MenesAMAkos Menes
- Jozsef BallaJBJozsef Balla
- Gyorgy BallaGBGyorgy Balla
Open Access
- 19 January 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (2) , 226
Abstract
Impaired mitochondrial function is associated with several metabolic diseases and health conditions, including insulin resistance and type 2 diabetes (T2DM), as well as ageing. The close relationship between the above-mentioned diseases and cardiovascular disease (CVD) (diabetic cardiomyopathy and age-related cardiovascular diseases) has long been known. Mitochondria have a crucial role: they are a primary source of energy produced in the form of ATP via fatty acid oxidation, tricarboxylic acid (TCA) cycle, and electron transport chain (ETC), and ATP synthase acts as a key regulator of cardiomyocyte survival. Mitochondrial medicine has been increasingly discussed as a promising therapeutic approach in the treatment of CVD. It is well known that vitamin B3 as an NAD+ precursor exists in several forms, e.g., nicotinic acid (niacin) and nicotinamide (NAM). These cofactors are central to cellular homeostasis, mitochondrial respiration, ATP production, and reactive oxygen species generation and inhibition. Increasing evidence suggests that the nicotinic acid derivative BGP-15 ((3-piperidine-2-hydroxy-1-propyl)-nicotinic amidoxime) improves cardiac function by reducing the incidence of arrhythmias and improves diastolic function in different animal models. Our team has valid reasons to assume that these cardioprotective effects of BGP-15 are based on its NAD+ precursor property. Our hypothesis was supported by an animal experiment where ageing ZDF rats were treated with BGP-15 for one year. Haemodynamic variables were measured with echocardiography to detect diabetic cardiomyopathy (DbCM) and age-related CVD as well. In the ZDF group, advanced HF was diagnosed, whereas the BGP-15-treated ZDF group showed diastolic dysfunction only. The significant difference between the two groups was supported by post-mortem Haematoxylin and eosin (HE) and Masson’s trichrome staining of cardiac tissues. Moreover, our hypothesis was further confirmed by the significantly elevated Cytochrome c oxidase (MTCO) and ATP synthase activity and expression detected with ELISA and Western blot analysis. To the best of our knowledge, this is the first study to demonstrate the protective effect of BGP-15 on cardiac mitochondrial respiration in an ageing ZDF model.Keywords
This publication has 33 references indexed in Scilit:
- Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic ProfilesPLOS ONE, 2012
- Mitochondrial dysfunction in diabetic cardiomyopathyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2010
- Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomographyCardiovascular Diabetology, 2009
- Improvement of Insulin Sensitivity by a Novel Drug, BGP-15, in Insulin-resistant Patients: A Proof of Concept Randomized Double-blind Clinical TrialHormone and Metabolic Research, 2009
- Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- The power to reduce: pyridine nucleotides – small molecules with a multitude of functionsBiochemical Journal, 2007
- Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathyClinica Chimica Acta, 2006
- Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damageBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- The physiological significance of heme oxygenaseInternational Journal of Biochemistry, 1988